Metraipolis › archive › dc_e80f19bcc3aa

Synergistic immunomodulation: integrating physical ablation with immune checkpoint inhibitors for metastatic colorectal carcinoma — Europe PMC PMID:42311659

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42311659
DOI
10.3389/fimmu.2026.1859114
License (as archived)
solo-consultazione
Archived
2026-10-31T22:07:01.621Z
SHA-256 of the archived text
87292a039b9a1dfc66b345bd38aca98afc73c2f9c9bb77827b7a3a133193df56
Stable URL of this page
https://metraipolis.com/documento/dc_e80f19bcc3aa

How to cite

Synergistic immunomodulation: integrating physical ablation with immune checkpoint inhibitors for metastatic colorectal carcinoma — Europe PMC PMID:42311659 — Europe PMC (en), https://europepmc.org/article/MED/42311659 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e80f19bcc3aa (Metraipolis archive dc_e80f19bcc3aa, sha256 87292a039b9a1dfc66b345bd38aca98afc73c2f9c9bb77827b7a3a133193df56)
BibTeX
@misc{dce80f19bcc3aa,
  title = {Synergistic immunomodulation: integrating physical ablation with immune checkpoint inhibitors for metastatic colorectal carcinoma — Europe PMC PMID:42311659},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42311659},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e80f19bcc3aa; sha256 87292a039b9a1dfc66b345bd38aca98afc73c2f9c9bb77827b7a3a133193df56},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42311659. Agents can read the archived copy with the MCP tool read_document.